Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Cancer patient getting treatment The number of people diagnosed with cancer increases with age, and that an aging population and increased number of cancer survivors will contribute to the increased cost. (Photo: Shutterstock)

Costs associated with cancer treatment are expected to exceed $245 billion by 2030, or nearly a 34% increase from 2015 billing, according to a new study.

The study published in the medical journal Cancer Epidemiology, Biomarkers & Prevention found the total costs varied by the type or location of the cancer, and the stage in which it was caught. Earlier treatment means lower costs, while end-of-life treatment often has the biggest cost.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

Nate Robson

Nate Robson is the U.S. Supreme Court and regulatory editor. Contact him at [email protected]. On Twitter: @Nate_Robson1.

More from this author



Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2022 ALM Global, LLC. All Rights Reserved.